Document Detail


Treatment of dural sinus thrombosis using selective catheterization and urokinase.
MedLine Citation:
PMID:  7611726     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Thrombosis of the cerebral dural venous sinuses, cortical draining veins, and deep cerebral veins is a rare clinical finding. Because of its low incidence and multiple etiologies, the optimum therapy for this condition will only be elucidated by a multicenter, randomized prospective study. At our institution, we favor early and aggressive management of cerebral venous sinus thrombosis with transfemoral, venous intradural infusions of the fibrinolytic agent urokinase. To date, treatment of only 13 patients using this technique has been reported in the English literature. This report adds 12 more such treated patients. Despite the presence of preinfusion infarcts in 5 patients, four of which were hemorrhagic, we incurred no major therapeutic morbidity. Functional sinus patency was achieved in 11 of 12 patients, with our only true failure occurring in an individual with symptoms of at least 2 months' duration. Good to excellent clinical outcome was achieved in 10 of 11 patients (one newborn had inadequate follow-up).
Authors:
M Horowitz; P Purdy; H Unwin; G Carstens; R Greenlee; J Hise; T Kopitnik; H Batjer; N Rollins; D Samson
Related Documents :
22340556 - Effect of combination therapy with alginate dressing and mouse epidermal growth factor ...
1963016 - Treatment of established venous thromboembolism with enoxaparin: preliminary report.
8892776 - Epidemiologic characteristics, management, and outcome of deep venous thrombosis in a t...
18349626 - Incidence of hematoma complication with heparin venous thrombosis prophylaxis after tra...
23131886 - Long-term effect of haloperidol, olanzapine, and risperidone on plasma prolactin levels...
24217166 - Pre-treatment before coronary artery bypass surgery improves post-operative outcomes in...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Annals of neurology     Volume:  38     ISSN:  0364-5134     ISO Abbreviation:  Ann. Neurol.     Publication Date:  1995 Jul 
Date Detail:
Created Date:  1995-08-16     Completed Date:  1995-08-16     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  7707449     Medline TA:  Ann Neurol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  58-67     Citation Subset:  IM    
Affiliation:
Department of Radiology, University of Texas Southwestern Medical Center at Dallas 75235-8896, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Brain / radiography
Catheterization
Cerebral Angiography
Child
Dura Mater / blood supply*
Female
Humans
Infant
Magnetic Resonance Imaging
Male
Safety
Sinus Thrombosis, Intracranial / drug therapy*,  radiography
Thrombolytic Therapy*
Tomography, X-Ray Computed
Urokinase-Type Plasminogen Activator / therapeutic use
Chemical
Reg. No./Substance:
EC 3.4.21.73/Urokinase-Type Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis.
Next Document:  Molecular and clinical correlations in spinocerebellar ataxia type 3 and Machado-Joseph disease.